NIAID Web Bulletin: "The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), both part of the National Institutes of Health, today announced a new research funding opportunity to design, develop and evaluate new strategies for curing HIV infection through partnerships among government, industry and academia. NIAID and NIMH will fund one or two grants with a total of $8.5 million per year for five years.
This request for applications (RFA), called “Martin Delaney Collaboratory: Towards an HIV-1 Cure,” is named in honor of influential AIDS activist Martin Delaney, who died of liver cancer in 2009. Mr. Delaney championed the concept of accelerating progress toward a cure for HIV infection through a public-private partnership in which the government contributes funding, regulatory oversight and coordination; industry contributes drug discovery, technology and expertise; and academia contributes innovative ideas and investigative capacity."
0 comments:
Post a Comment